BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 91 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $181,000 | +269.4% | 28,600 | +156.1% | 0.00% | +300.0% |
Q3 2016 | $49,000 | -94.2% | 11,168 | -86.4% | 0.00% | -88.9% |
Q4 2015 | $850,000 | -16.7% | 82,374 | -7.9% | 0.01% | -10.0% |
Q3 2015 | $1,020,000 | +318.0% | 89,400 | +345.5% | 0.01% | +400.0% |
Q4 2014 | $244,000 | – | 20,067 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |